Throughput

Fluofarma's technology keeps your project moving at high speed throughout the R&D process. Our technology platform enables large-scale screening programs, with 2000 wells tested a day and 2500 individual cells analyzed per well.

As shown in the Figure below, the Fluofarma HCS technology substantially boosts the number of compounds that can be analyzed. The more compounds you test, the more you improve your chances of identifying a blockbuster.

Fluofarma (green) vs. Standard (red) drug discovery process:  

Drug Discovery process with High Content Screening

► With Fluofarma, understand a large number of compounds and optimize your decision making.

 

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal Cell Research.

    Read more [+]

  • Publication

    Fluofarma cited in a Biocompare featured article “Flow Cytometry Gets a Makeover”

    Read more [+]

  • Press Release

    Roche adopts Fluofarma’s high-content screening platform.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "Analytical Chemistry".

    Read more [+]

  • AACR 2010

    Fluofarma will be exhibitor at AACR 2010, in Washington from April 17th to 21st.

    Read more [+]

  • WPC 2010

    Fluofarma will be exhibitor at World Pharmaceutical Congress 2010, in Philadelphia from June 15th to 17th.

    Read more [+]

Roche adopts Fluofarma’s platform
October 19, 2009 – Fluofarma announced today that it entered into a multi-year agreement with Roche.
Read More